Grants and Contracts per year
Grants and Contracts Details
Description
Patients with relapsed Acute Lymphoblastic Leukemia (ALL) have a poor prognosis because
their therapeutic options are limited. Relapse is thought to arise from leukemia stem cells, which have
the unique ability to self-renew to reform tumor from a single cell. These cells are rare in human
disease and mouse models, making up
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/14 → 4/30/17 |
Funding
- National Institute of General Medical Sciences
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
COBRE for the Center for Molecular Medicine
Hersh, L., Creamer, T., Dutch, R., Mendenhall, M., Rodgers, D., Spielmann, H., Watt, D., Zhu, H. & Whiteheart, S.
National Institute of General Medical Sciences
7/1/14 → 4/30/17
Project: Research project